133 related articles for article (PubMed ID: 36098476)
1. Prevalence of New-Onset Tinnitus after COVID-19 Vaccination with Comparison to Other Vaccinations.
Dorney I; Bobak L; Otteson T; Kaelber DC
Laryngoscope; 2023 Jul; 133(7):1722-1725. PubMed ID: 36098476
[TBL] [Abstract][Full Text] [Related]
2. Risk of New Retinal Vascular Occlusion After mRNA COVID-19 Vaccination Within Aggregated Electronic Health Record Data.
Dorney I; Shaia J; Kaelber DC; Talcott KE; Singh RP
JAMA Ophthalmol; 2023 May; 141(5):441-447. PubMed ID: 37052897
[TBL] [Abstract][Full Text] [Related]
3. Association between community-level political affiliation and peripartum vaccination.
Post S; Lynch CD; Costantine MM; Fox B; Wu J; Kiefer MK; Rood KM; Landon MB; Grobman WA; Venkatesh KK
Am J Obstet Gynecol MFM; 2023 Aug; 5(8):101007. PubMed ID: 37156464
[TBL] [Abstract][Full Text] [Related]
4. Association between acceptance of routine pregnancy vaccinations and COVID-19 vaccine uptake in pregnant patients.
Ha L; Levian C; Greene N; Goldfarb I; Hirsch A; Naqvi M
J Infect; 2023 Dec; 87(6):551-555. PubMed ID: 37865294
[TBL] [Abstract][Full Text] [Related]
5. Influenza, Tdap, and COVID-19 Vaccination Coverage and Hesitancy Among Pregnant Women - United States, April 2023.
Razzaghi H; Kahn KE; Calhoun K; Garacci E; Skoff TH; Ellington SR; Jatlaoui TC; Black CL
MMWR Morb Mortal Wkly Rep; 2023 Sep; 72(39):1065-1071. PubMed ID: 37768879
[TBL] [Abstract][Full Text] [Related]
6. A genetically inactivated two-component acellular pertussis vaccine, alone or combined with tetanus and reduced-dose diphtheria vaccines, in adolescents: a phase 2/3, randomised controlled non-inferiority trial.
Sricharoenchai S; Sirivichayakul C; Chokephaibulkit K; Pitisuttithum P; Dhitavat J; Pitisuthitham A; Phongsamart W; Boonnak K; Lapphra K; Sabmee Y; Wittawatmongkol O; Chinwangso P; Poredi IK; Petre J; Thai PH; Viviani S
Lancet Infect Dis; 2018 Jan; 18(1):58-67. PubMed ID: 29066131
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and safety of reduced-antigen tetanus, diphtheria and acellular pertussis vaccination in adults treated for obstructive airway diseases.
Van den Steen P; Cheuvart B; Deraedt Q; Valdes Verelst L; Shamarina D
Hum Vaccin Immunother; 2023 Dec; 19(1):2159731. PubMed ID: 36746754
[TBL] [Abstract][Full Text] [Related]
8. Predictors of tetanus, diphtheria, acellular pertussis and influenza vaccination during pregnancy among full-term deliveries in a medically underserved population.
Doraivelu K; Boulet SL; Biswas HH; Adams JC; Haddad LB; Jamieson DJ
Vaccine; 2019 Sep; 37(41):6054-6059. PubMed ID: 31471152
[TBL] [Abstract][Full Text] [Related]
9. Assessment of safety and efficacy against Bordetella pertussis of a new tetanus-reduced dose diphtheria-acellular pertussis vaccine in a murine model.
Kwon HJ; Han SB; Kim BR; Kang KR; Huh DH; Choi GS; Ahn DH; Kang JH
BMC Infect Dis; 2017 Apr; 17(1):247. PubMed ID: 28376777
[TBL] [Abstract][Full Text] [Related]
10. A randomised, double-blind, non-inferiority clinical trial on the safety and immunogenicity of a tetanus, diphtheria and monocomponent acellular pertussis (TdaP) vaccine in comparison to a tetanus and diphtheria (Td) vaccine when given as booster vaccinations to healthy adults.
Thierry-Carstensen B; Jordan K; Uhlving HH; Dalby T; Sørensen C; Jensen AM; Heilmann C
Vaccine; 2012 Aug; 30(37):5464-71. PubMed ID: 22776216
[TBL] [Abstract][Full Text] [Related]
11. Association between social vulnerability and influenza and tetanus-diphtheria-acellular pertussis vaccination in pregnant and postpartum individuals.
Kiefer MK; Mehl R; Costantine MM; Landon MB; Bartholomew A; Mallampati D; Manuck T; Grobman W; Rood KM; Venkatesh KK
Am J Obstet Gynecol MFM; 2022 May; 4(3):100603. PubMed ID: 35240346
[TBL] [Abstract][Full Text] [Related]
12. Vaccination of adults 65 years of age and older with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Boostrix(®)): results of two randomized trials.
Weston WM; Friedland LR; Wu X; Howe B
Vaccine; 2012 Feb; 30(9):1721-8. PubMed ID: 22212127
[TBL] [Abstract][Full Text] [Related]
13. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP).
Broder KR; Cortese MM; Iskander JK; Kretsinger K; Slade BA; Brown KH; Mijalski CM; Tiwari T; Weston EJ; Cohn AC; Srivastava PU; Moran JS; Schwartz B; Murphy TV;
MMWR Recomm Rep; 2006 Mar; 55(RR-3):1-34. PubMed ID: 16557217
[TBL] [Abstract][Full Text] [Related]
14. Maternal pertussis vaccination and its effects on the immune response of infants aged up to 12 months in the Netherlands: an open-label, parallel, randomised controlled trial.
Barug D; Pronk I; van Houten MA; Versteegh FGA; Knol MJ; van de Kassteele J; Berbers GAM; Sanders EAM; Rots NY
Lancet Infect Dis; 2019 Apr; 19(4):392-401. PubMed ID: 30938299
[TBL] [Abstract][Full Text] [Related]
15. Reduced-antigen, combined diphtheria, tetanus and acellular pertussis vaccine, adsorbed (Boostrix®): a review of its properties and use as a single-dose booster immunization.
McCormack PL
Drugs; 2012 Sep; 72(13):1765-91. PubMed ID: 22931522
[TBL] [Abstract][Full Text] [Related]
16. Tetanus, diphtheria, and acellular pertussis vaccination during pregnancy and reduced risk of infant acute respiratory infections.
Khodr ZG; Bukowinski AT; Gumbs GR; Conlin AMS
Vaccine; 2017 Oct; 35(42):5603-5610. PubMed ID: 28916245
[TBL] [Abstract][Full Text] [Related]
17. Pertussis and influenza immunization: perceived attitude and decision of postpartum patients.
Hebballi NB; Parker T; Garcia EI; Ferguson DM; Lesser S; Tsao K; Broussard M; Wootton SH
BMC Pregnancy Childbirth; 2022 Dec; 22(1):975. PubMed ID: 36577947
[TBL] [Abstract][Full Text] [Related]
18. Impact of tetanus, diphtheria, and acellular pertussis (Tdap) vaccine use in wound management on health care costs and pertussis cases.
Talbird SE; Graham J; Mauskopf J; Masseria C; Krishnarajah G
J Manag Care Spec Pharm; 2015 Jan; 21(1):88-99, 99a-c. PubMed ID: 25562776
[TBL] [Abstract][Full Text] [Related]
19. Antibody persistence and safety and immunogenicity of a second booster dose nine years after a first booster vaccination with a reduced antigen diphtheria-tetanus-acellular pertussis vaccine (Tdap) in adults.
Brandon D; Kimmel M; Kuriyakose SO; Kostanyan L; Mesaros N
Vaccine; 2018 Oct; 36(42):6325-6333. PubMed ID: 30197282
[TBL] [Abstract][Full Text] [Related]
20. Exploring Tdap and influenza vaccine uptake and its determinants in pregnancy: a cross-sectional study.
Brillo E; Ciampoletti M; Tosto V; Buonomo E
Ann Ig; 2022; 34(4):358-374. PubMed ID: 35195239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
